# ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

> **NCT04367740** · — · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 6313 (actual)

## Conditions studied

- Asymptomatic Condition
- Infection Viral
- Coronavirus Infections
- Severe Acute Respiratory Syndrome Coronavirus 2
- Coronaviridae Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Disease

## Interventions

- **DIAGNOSTIC_TEST:** To assess for development of IgG antibodies against SARS-CoV2

## Key facts

- **NCT ID:** NCT04367740
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2022-02-24
- **Final completion:** 2022-02-28
- **Target enrollment:** 6313 (ACTUAL)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367740, "ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04367740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*